Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020

Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020

  • July 2020 •
  • 48 pages •
  • Report ID: 5948699 •
  • Format: PDF
Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020

Summary
The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space.The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions.

A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Scope
- Global epidemiology metrics and trends
- Snapshot of epidemiological trends to date in the top three most-affected countries
- An overview of the pipeline for antivirals and vaccines
- Summary of available efficacy data
- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
- Highlights in deal-making trends, particularly public-private partnerships
- Spotlight on social media coverage

Reasons to Buy
- Understand the global epidemiology of COVID-19
- Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
- Access an overview of the pipeline for therapeutics and vaccines
- Stay up to date on available efficacy data for pipeline-stage products
- View the clinical trials landscape by across key attributes
- Get up to speed on highlights in deal-making trends, particularly public-private partnerships
- Monitor top trends in social media coverage
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.